Unlocking Q3 Potential of Ares Capital (ARCC): Exploring Wall Street Estimates for Key Metrics
Werte in diesem Artikel
The upcoming report from Ares Capital (ARCC) is expected to reveal quarterly earnings of $0.59 per share, indicating no change from the year-ago quarter compared to the year-ago period. Analysts forecast revenues of $766.58 million, representing an increase of 17% year over year.The consensus EPS estimate for the quarter has remained unchanged over the last 30 days. This represents how the covering analysts, as a whole, have reassessed their initial estimates during this timeframe.Before a company reveals its earnings, it is vital to take into account any changes in earnings projections. These revisions play a pivotal role in predicting the possible reactions of investors toward the stock. Multiple empirical studies have consistently shown a strong association between trends in earnings estimates and the short-term price movements of a stock.While it's common for investors to rely on consensus earnings and revenue estimates for assessing how the business may have performed during the quarter, exploring analysts' forecasts for key metrics can yield valuable insights.In light of this perspective, let's dive into the average estimates of certain Ares Capital metrics that are commonly tracked and forecasted by Wall Street analysts.The average prediction of analysts places 'Dividend income' at $141.38 million. The estimate is in contrast to the year-ago figure of $128 million.Analysts' assessment points toward 'Other Income' reaching $15.27 million. The estimate compares to the year-ago value of $12 million.Analysts expect 'Capital Structuring Service Fees' to come in at $44.31 million. The estimate is in contrast to the year-ago figure of $20 million.It is projected by analysts that the 'Interest Income From Investments' will reach $559.50 million. Compared to the present estimate, the company reported $495 million in the same quarter last year.View all Key Company Metrics for Ares Capital here>>>Shares of Ares Capital have demonstrated returns of +3.2% over the past month compared to the Zacks S&P 500 composite's +2% change. With a Zacks Rank #4 (Sell), ARCC is expected to lag the overall market performance in the near future. You can see the complete list of today's Zacks Rank #1 (Strong Buy) stocks here >>>>Only $1 to See All Zacks' Buys and SellsWe're not kidding.Several years ago, we shocked our members by offering them 30-day access to all our picks for the total sum of only $1. No obligation to spend another cent.Thousands have taken advantage of this opportunity. Thousands did not - they thought there must be a catch. Yes, we do have a reason. We want you to get acquainted with our portfolio services like Surprise Trader, Stocks Under $10, Technology Innovators,and more, that closed 228 positions with double- and triple-digit gains in 2023 alone.See Stocks Now >>Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Ares Capital Corporation (ARCC): Free Stock Analysis ReportTo read this article on Zacks.com click here.Zacks Investment ResearchWeiter zum vollständigen Artikel bei Zacks
Ausgewählte Hebelprodukte auf Ares Capital
Mit Knock-outs können spekulative Anleger überproportional an Kursbewegungen partizipieren. Wählen Sie einfach den gewünschten Hebel und wir zeigen Ihnen passende Open-End Produkte auf Ares Capital
Der Hebel muss zwischen 2 und 20 liegen
Name | Hebel | KO | Emittent |
---|
Name | Hebel | KO | Emittent |
---|
Quelle: Zacks
Nachrichten zu Ares Capital CorpShs
Analysen zu Ares Capital CorpShs
Datum | Rating | Analyst | |
---|---|---|---|
23.08.2019 | Ares Capital Neutral | Compass Point | |
19.08.2019 | Ares Capital Outperform | BMO Capital Markets | |
21.09.2017 | Ares Capital Outperform | Oppenheimer & Co. Inc. | |
28.06.2016 | Ares Capital Neutral | National Securities | |
25.02.2016 | Ares Capital Overweight | Barclays Capital |
Datum | Rating | Analyst | |
---|---|---|---|
19.08.2019 | Ares Capital Outperform | BMO Capital Markets | |
21.09.2017 | Ares Capital Outperform | Oppenheimer & Co. Inc. | |
25.02.2016 | Ares Capital Overweight | Barclays Capital | |
30.09.2015 | Ares Capital Buy | D.A. Davidson & Co. | |
13.02.2015 | Ares Capital Market Perform | BMO Capital Markets |
Datum | Rating | Analyst | |
---|---|---|---|
23.08.2019 | Ares Capital Neutral | Compass Point | |
28.06.2016 | Ares Capital Neutral | National Securities | |
05.05.2015 | Ares Capital Hold | BB&T Capital Markets | |
20.08.2009 | Allied Capital market perform | Keefe, Bruyette & Woods, Inc. | |
06.02.2007 | Update Allied Capital Corp.: Hold | AG Edwards |
Datum | Rating | Analyst | |
---|---|---|---|
06.12.2005 | Update Allied Capital Corp.: Underperform | Harris Nesbitt |
Um die Übersicht zu verbessern, haben Sie die Möglichkeit, die Analysen für Ares Capital CorpShs nach folgenden Kriterien zu filtern.
Alle: Alle Empfehlungen